Getting to grips with . . .

Experimental cancer drug may boost Covid immune response, study finds

Researchers say the antiviral triggers ‘highly effective’ immune response to string of respiratory diseases

3 Feb 2021

NHS workers in PPE take a patient into Queens Hospital, London

Justin Setterfield/Getty Images

To continue reading for free, please register your details below

We will use the details you have shared to manage your registration. You agree to the processing, storage, sharing and use of this information for the purpose of managing your registration as described in our Privacy Policy.

Would you like to receive The WeekDay newsletter?

The WeekDay newsletter provides you with a daily digest of news and analysis.

We will use the details you have shared to manage your newsletter subscription. You agree to the processing, storage, sharing and use of this information for the purpose of managing your subscription as described in our Privacy Policy.

We will use the information you have shared for carefully considered and specific purposes, where we believe we have a legitimate case to do so, for example to send you communications about similar products and services we offer. You can find out more about our legitimate interest activity in our Privacy Policy.

If you wish to object to the use of your data in this way, please tick here.

'We' includes The Week and other Dennis Group brands as detailed here.